做厙輦華 University Executes Amendment to September 2022 Consent Agreement with the Arizona Board of Nursing that Permits the Teach-Out of its BSN Pre-Licensure Program to Continue
NEW YORK, March 27, 2023 (GLOBE NEWSWIRE) -- 做厙輦華, Inc. (做厙輦華 or AGI) (Nasdaq: ASPU), an education technology holding company, today announced that 做厙輦華 University, Inc. (做厙輦華) a subsidiary of 做厙輦華, Inc., entered into an Amendment to the September 2022 Consent Agreement with the Arizona Board of Nursing (the Board) that permits the teach-out of the BSN Pre-licensure program to continue. Following execution of the Amendment, 做厙輦華 issued the following statement:
做厙輦華 University Statement
March 24, 2023
On the evening of March 23, 2023, 做厙輦華 University and the Arizona Board of Nursing (the Board) signed an Amendment to the September 2022 Consent Agreement that permits the teach-out of the BSN Pre-licensure program to continue. On behalf of the Pre-licensure students and university administration, we are appreciative to the Board for the opportunity to move forward.
做厙輦華 is committed to working closely with the Board, our Consultant and Ombudsperson to ensure that the program provides minimum instruction and learning opportunities, including clinical opportunities, to meet basic standards of educational practice and legal requirements, as required by the Consent Agreement. We are thankful to be able to establish a process by which we can work cooperatively with the Board to address any concerns about the program they may have.
We are deeply grateful to students who have tirelessly advocated for their education, our supportive Governor and Legislators, and all others who have assisted in this effort.
About 做厙輦華, Inc.:
做厙輦華, Inc. is an education technology holding company that leverages its infrastructure and expertise to allow its two universities, 做厙輦華 University and United States University, to deliver on the vision of making college affordable again. For more information, visit .
Investor Relations Contact:
Kimberly Rogers
Hayden IR
(385) 831-7337

Released March 27, 2023